ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Abliva AB publ

Abliva AB publ (ABLIS)

0.2375
-0.0085
( -3.46% )
Actualizado: 06:11:44
Realtime Data

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
0.2375
Postura de Compra
0.238
Postura de Venta
0.241
Volume Operado de la Acción
406,855
0.2375 Rango del Día 0.2415
0.00 Rango de 52 semanas 0.00
Precio Anterior
0.246
Precio de Apertura
0.2415
Última hora de negociación
04:53:15
Volumen promedio (3 m)
-
Volumen financiero
SEK 97,084
Precio Promedio Ponderado
0.23862

ABLIS Últimas noticias

AIM Cancellation - 4d Pharma Plc

AIM 16 February 2023 NOTICE 16/02/2023 - 07:00 NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM Pursuant to AIM Rule 41 the following securities have been cancelled from trading on AIM with...

IN BRIEF: 4D Pharma shares cancelled from trading on London's AIM

eeds-based pharmaceutical firm - Notes cancellation of its shares on AIM from Thursday, after it entered into administ ...

4d Pharma PLC Cancellation of admission to trading on AIM

4d Pharma PLC 15 February 2023 4D pharma plc (in administration) Cancellation of admission to trading on AIM Leeds, UK, 15 February 2023 - 4D pharma plc (the "Company") (AIM: DDDD...

TRADING UPDATES: GCP Infra hails NAV rise; Jadestone profits from oil

The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by ...

4d Pharma PLC Updated Results from Renal Cell Carcinoma Cohort

4d Pharma PLC 02 February 2023 4D pharma plc (in administration) 4D pharma Announces Updated Results from the Renal Cell Carcinoma Cohort of the Phase I/II Study of the Combination of MRx0518 and...

4d Pharma PLC Result of Meeting

4d Pharma PLC 16 January 2023 4D pharma Announces Result of General Meeting Leeds, UK - January 16, 2023 - 4D pharma plc (AIM: DDDD) (in administration), a pharmaceutical company leading the...

4D Pharma seeks approval for equity fundraise to lift suspension

4D Pharma PLC on Friday said it was seeking shareholder approval for a USD15.0 million cash raise, as it works to lif ...

4d Pharma PLC Update on Administration and Suspension of Trading

4d Pharma PLC 30 December 2022 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON PUBLICATION OF THIS ANNOUNCEMENT THIS INFORMATION...

4D Pharma says trial results show Blautix eases IBS symptoms

4D Pharma PLC said on Wednesday that its Blautix phase 2 clinical trial results showed the treatment had a positive e ...

4d Pharma PLC Blautix Phase II Clinical Trial Results Published

4d Pharma PLC 16 November 2022 4D pharma's Blautix(R) Phase II Clinical Trial Results Published in Alimentary Pharmacology & Therapeutics Leeds, UK - November 15, 2022 - 4D pharma plc...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ISOFOSIsofol Medical AB
SEK 2.64
(49.49%)
9.85k
AG1DAUTO1 Group
7.925 €
(15.86%)
12.73k
ASAOAtlantic Sapphire ASA
kr 6.963
(14.69%)
1.51k
JDEPAJDE Peets NV
21.10 €
(14.55%)
55.79k
TMVDTeamViewer SE
12.38 €
(13.01%)
38.81k
LOCALPSolocal Groupe
0.00355 €
(-34.26%)
7.38M
2HRADH & R GmbH & Co
4.10 €
(-18.33%)
197
PROFBSProfilgruppen
SEK 122.00
(-9.96%)
101
GSC1DGesco SE
13.80 €
(-9.21%)
194
EBUSAEbusco Holding NV
1.305 €
(-8.87%)
13.15k
LOCALPSolocal Groupe
0.00355 €
(-34.26%)
7.38M
ISPMIntesa Sanpaolo Spa
3.7845 €
(-0.32%)
1.01M
CABKECaixaBank SA
5.276 €
(-2.76%)
944.77k
FINGBSFingerprint Cards AB
SEK 0.0761
(0.00%)
850.08k
BBVAEBanco Bilbao Vizcaya Argentaria SA
9.81 €
(-3.78%)
650.35k
rosemountbomber rosemountbomber 1 minuto hace
Nope, they recognized the 15 million in Q2.
AMRN
Atlanta1 Atlanta1 2 minutos hace
ROFLMFAO
VIVK
dshade dshade 2 minutos hace
Not strange at all. Have you bought any? I have. Still bidding as well. Buying will come heavy AFTER the news. Still under radar with old symbol as well.
ECSL
stock1ace1 stock1ace1 2 minutos hace
Vbiv ..11s
jay_tee jay_tee 2 minutos hace
Heck IDK if that’s even accurate. They’ve had so many compliance issues I’m lost….not sure how our no bidder will save the day….
RNVA
PonkenPlonken PonkenPlonken 3 minutos hace
MASSIVE bounce coming
MULN
RealDutch RealDutch 3 minutos hace
But I note that estimates regarding the two first verticals have come down to one third of what they were

How is that? Is $250 fair value for gold (SIRI) not enough for you? It depends on which cycle rate you are using. There is a big difference between 3 days and 15 days.
SIRI
sylvia07 sylvia07 4 minutos hace
I don't know what you are talking about but I expect this to blast off anytime with all the good news and naked shorts.
GRST
Foogie88 Foogie88 4 minutos hace
I just put that clown on ignore. He’s here everyday shouting the same thing 24/7. Only thing he’s doing is taking in oxygen. Nobody could possibly read what that clown has to say every single day.
NWBO
jimmybob jimmybob 4 minutos hace
$PYPL:

Bernstein upgrades to Outperform from Perform - raises PT to $78 from $71

$MS keeps at Equal-weight - raises PT to $71 from $67

Canaccord maintains at Buy - keeps $80 PT

JMP Securities reiterates Buy - keeps $80 PT
MS PYPL
jimmybob jimmybob 5 minutos hace
GM FOLKSSS
JRoon71 JRoon71 5 minutos hace
Product Revenue was $47M, but we got the $15M milestone from Edding

Update on Amarin's Share Repurchase Program

On January 10, 2024, Amarin announced plans to initiate a share repurchase program to purchase up to $50.0 million of the Company's ordinary shares held in th
AMRN
georgie18 georgie18 6 minutos hace
Good Morning...🥳
jay_tee jay_tee 6 minutos hace
FOXO has until Dec. 12 2024 to get their plan accepted before delisting….

https://www.businesswire.com/news/home/20230831780937/en/FOXO-Technologies-Inc.-Announces-NYSE-American-Acceptance-of-Compliance-Plan
FOXO
georgie18 georgie18 6 minutos hace
PMEC...88s clearing here on 5Million Volume...🥳

georgie18

Member Level
Re: georgie18 post# 638773

Tuesday, July 30, 2024 5:39:08 PM

Post#
651877
of 651893
PMEC...$1.01...hit $1.26...high...🥳
PMEC
hnbadger1 hnbadger1 6 minutos hace
“ trial extension for a duration of up to 96 additional weeks was completed in June”

Termi0208 on stock twits-
I think this has been not mentioned.
From form S-3:
"A subsequent long-term open label extension study of ANAVEX®2-73, entitled the
ATT
AVXL
georgie18 georgie18 6 minutos hace
PMEC...88s clearing here on 5Million Volume...🥳

georgie18

Member Level
Re: georgie18 post# 638773

Tuesday, July 30, 2024 5:39:08 PM

Post#
651877
of 651893
PMEC...$1.01...hit $1.26...high...🥳
PMEC
georgie18 georgie18 7 minutos hace
PMEC...88s clearing here on 5Million Volume...🥳

georgie18

Member Level
Re: georgie18 post# 638773

Tuesday, July 30, 2024 5:39:08 PM

Post#
651877
of 651893
PMEC...$1.01...hit $1.26...high...🥳
PMEC
Hummingbird2 Hummingbird2 7 minutos hace
https://x.com/ham59591shorts/status/1818594741186871411


$GTII
GTII
JRoon71 JRoon71 8 minutos hace
https://www.sec.gov/ix?doc=/Archives/edgar/data/0000897448/000095017024088234/amrn-20240731.htm
AMRN
Mother Lode Mother Lode 9 minutos hace
STEINHAUSEN, Switzerland, July 31, 2024 (GLOBE NEWSWIRE) -- Transocean Ltd. (NYSE: RIG) (“Transocean”) today announced a 1,095-day contract for the Deepwater Invictus with bp in the U.S. Gulf of Mexico. The program is expected to commence in the first quarter of 2025 and is estimated to contribute a
RIG
subslover subslover 9 minutos hace
Bionomics Announces Successful End-of-Phase 2 Meeting with the FDA on the Development of BNC210 in Post-Traumatic Stress Disorder
Successful End-of-Phase 2 (EoP2) meeting with U.S. Food and Drug Administration (FDA) provides a potential path to New Drug Application (NDA) submission for BNC210
BNOX
ksquared ksquared 9 minutos hace
Nothing DEI about this bunch...
Sorry, Folks. I'm tired of letting politics dictate my life and keep me from things I enjoy... gymnastics, swimming, & diving.
These ladies were incredible. The spectators were from both sides of the political aisle.
When they to

Su Consulta Reciente

Delayed Upgrade Clock